BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 22170554)

  • 21. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
    Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
    Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Sabouri AH; Saito M; Lloyd AL; Vine AM; Witkover AW; Furukawa Y; Izumo S; Arimura K; Marshall SE; Usuku K; Bangham CR; Osame M
    J Infect Dis; 2004 Oct; 190(7):1279-85. PubMed ID: 15346339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
    Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
    Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
    Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
    J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
    Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
    J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delimitation of the upstream region of NFKBIA gene associated with HTLV-1-associated myelopathy/tropical spastic paraparesis using candidate Tag-SNPs in Peruvian HTLV-1 infected individuals.
    Posadas AE; Rosado JJ; Gotuzzo E; Talledo MJ
    Infect Genet Evol; 2019 Nov; 75():103929. PubMed ID: 31226330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
    Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
    J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
    Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
    Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Kodama D; Saito M; Matsumoto W; Sabouri AH; Izumo S; Arimura K; Usuku K; Bangham CR; Osame M
    J Neuroimmunol; 2004 Nov; 156(1-2):188-94. PubMed ID: 15465610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Matsuura E; Kodama D; Tashiro Y; Matsuzaki T; Kubota R; Izumo S; Takashima H
    Retrovirology; 2017 Apr; 14(1):26. PubMed ID: 28420387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
    Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
    Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
    Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
    J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of HTLV-1 Tax genetic diversity with HTLV-1 associated myelopathy/tropical spastic paraparesis progression and HTLV-1a genotypes in an HTLV-1 endemic region in Argentina.
    Iñiguez AM; Gastaldello R; Otsuki K; Balangero M; Carvalho Costa F; Remondegui C; Paula Vicente AC; Gallego S
    J Med Virol; 2010 Aug; 82(8):1438-41. PubMed ID: 20572090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.